Since January 2026, there has been a noticeable uptick in research enthusiasm surrounding publicly offered funds, with a pronounced shift toward technological growth sectors as a pivotal area for investment strategies. Industries at the forefront of this trend include AI applications, commercial aerospace, innovative pharmaceuticals, and semiconductors, all of which have drawn substantial interest. A diverse array of companies, including Dajin Heavy Industry, Xiangyu Medical, Hitrans Intelligence, Aipon Medical, ZKTECO, Meiao Medical, Biotest Biotech, Techchem Technology, 37 Interactive Entertainment, and Aerospace Macrography, have become the subjects of research by over a hundred institutions. Numerous fund managers have delved deeply into the operations of leading firms within these niche sectors, placing a special emphasis on high-quality enterprises that boast significant technological barriers and clearly defined application scenarios. This approach underscores the institutions' dual focus on achieving 'technological breakthroughs + tangible performance results' within the technology sector.